Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. VATE
VATE logo

VATE Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
5.470
Open
4.820
VWAP
5.23
Vol
89.34K
Mkt Cap
62.63M
Low
4.820
Amount
466.94K
EV/EBITDA(TTM)
10.56
Total Shares
13.65M
EV
626.13M
EV/OCF(TTM)
4.27
P/S(TTM)
0.05
Innovate Corp. is a diversified holding company. The Company has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure (DBMG), Life Sciences (Pansend), and Spectrum. The DBMG segment consists of DBM Global Inc., which is a fully integrated construction company offering both construction and professional services primarily through its core subsidiaries. It provides services, including design-assist, modularization, fabrication and erection of structural steel, heavy steel plate, trusses and girders, heavy equipment installation, as well as facility services for maintenance and shutdowns. Life Sciences segment consists of Pansend Life Sciences, LLC, which is focused on supporting healthcare and biotechnology product development. Spectrum segment consists of HC2 Broadcasting Holdings Inc. and its subsidiaries. It owns and operates broadcast television stations throughout the United States.
Show More

Events Timeline

(ET)
2026-02-02
09:00:00
INNOVATE Announces DBM Global to Pay $5M Cash Dividend
select
2025-12-16 (ET)
2025-12-16
08:10:00
INNOVATE Announces MediBeacon FDA Approval for Next-Gen TGFRTM System
select
2025-10-21 (ET)
2025-10-21
08:07:02
INNOVATE Corp. granted permission to market Transdermal GFR System in China
select
2025-09-09 (ET)
2025-09-09
08:41:46
INNOVATE's R2 Sees 88% Year-Over-Year Revenue Growth in Q2
select
2025-07-17 (ET)
2025-07-17
08:48:12
INNOVATE Corp. launches indebtedness refinancing transactions
select
2025-05-28 (ET)
2025-05-28
12:02:04
INNOVATE Corp. falls -14.0%
select
2025-05-27 (ET)
2025-05-27
12:01:48
INNOVATE Corp. rises 23.4%
select
2025-03-31 (ET)
2025-03-31
16:16:33
INNOVATE Corp. reports Q4 EPS ($1.29) vs ($1.22) last year
select
2025-02-25 (ET)
2025-02-25
09:16:04
INNOVATE Corp. announces NMPA approval of MediBeacon TGFR System
select

News

seekingalpha
9.5
03-26seekingalpha
INNOVATE Corp. Reports Q4 2025 Earnings Highlights
  • Financial Performance Boost: INNOVATE Corp. reported consolidated revenues of $382.7 million for Q4, a 61.7% increase year-over-year, with adjusted EBITDA of $24.5 million, demonstrating the company's financial discipline and execution amid mixed market conditions.
  • DBM Business Growth: DBM Global achieved Q4 revenues of $373.9 million and adjusted EBITDA of $28 million, despite a year-over-year gross margin compression of 350 basis points to 14.7%, the adjusted backlog grew to $1.8 billion, reflecting improved market demand.
  • MediBeacon Innovation Progress: MediBeacon received FDA approval for its next-generation TGFR System and launched sales initiatives in the U.S., while beginning initial commercialization in China, expected to drive further placements at leading institutions and enhance the company's competitiveness in the life sciences sector.
  • R2 Business Expansion: R2 reported Q4 revenues of $3.1 million, with record annual revenue of $12.5 million, restructuring its China distribution deal to secure a minimum of 600 systems over three years valued at approximately $10 million, indicating strong international demand support.
seekingalpha
9.5
03-26seekingalpha
Innovate Reports Q4 2025 Financial Results with Significant Revenue Growth
  • Financial Highlights: Innovate reported a Q4 2025 GAAP EPS of -$0.58, indicating a loss, yet achieved revenues of $382.7 million, reflecting a robust 61.7% year-over-year growth that underscores the company's strong market potential.
  • Cash Position: As of December 31, 2025, Innovate's cash and cash equivalents totaled $112.1 million, a significant increase from $48.8 million in the same period of 2024, indicating improved liquidity that supports future investments and operations.
  • Non-Operating Segment Performance: The Non-Operating Corporate segment reported cash and cash equivalents of $4.2 million as of December 31, 2025, down from $13.8 million in 2024, highlighting funding pressures and the need for operational optimization in this area.
  • Future Outlook: Despite current losses, Innovate's strong revenue growth and improved cash flow position provide a solid foundation for future business expansion and market competitiveness, likely attracting increased investor interest.
moomoo
9.5
03-26moomoo
INNOVATE CORP. Reports Q4 EPS of USD -0.58
  • Earnings Report: Innovate Corp reported a Q4 EPS of USD -0.58, indicating a loss for the quarter.
  • Financial Performance: The negative earnings per share suggest challenges in profitability during the reporting period.
moomoo
9.5
03-26moomoo
INNOVATE CORP. REPORTS Q4 REVENUE OF USD 382.7 MILLION
  • Company Overview: Innovate Corp reported a revenue of USD 382.7 million for the fourth quarter.
  • Financial Performance: The revenue figure indicates the company's financial performance during the specified period.
moomoo
9.5
03-26moomoo
INNOVATE CORP. REPORTS Q4 NET LOSS OF USD 7.8 MILLION
  • Company Overview: Innovate Corp reported a net income of USD -7.8 million for the fourth quarter.
  • Financial Performance: The negative net income indicates a loss for the company during this period.
Fool
6.5
02-17Fool
Arena Capital Advisors Fully Exits Diebold Nixdorf Position
  • Complete Liquidation: Arena Capital Advisors disclosed on February 3, 2026, that it sold its entire position of 611,495 shares in Diebold Nixdorf for an estimated value of $34.9 million, indicating a shift in confidence regarding the stock.
  • Portfolio Adjustment: Previously, Diebold Nixdorf represented 15% of Arena Capital's securities portfolio, and this liquidation aligns with a broader 31% reduction in the value of their disclosed holdings, reflecting a strategic repositioning.
  • Market Performance: As of February 3, 2026, Diebold Nixdorf shares traded at $70.99, marking a 68.8% increase over the past year, significantly outperforming the S&P 500 by 53.4 percentage points, showcasing its strong market position.
  • Investment Strategy: Arena Capital likely acquired Diebold Nixdorf at lower prices and opted to sell now to raise cash for investments in assets with better return prospects, indicating a strategic shift in their value investment approach.

Valuation Metrics

The current forward P/E ratio for Innovate Corp (VATE.N) is -0.87, compared to its 5-year average forward P/E of -2.97. For a more detailed relative valuation and DCF analysis to assess Innovate Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-2.97
Current PE
-0.87
Overvalued PE
-0.77
Undervalued PE
-5.17

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
42.16
Current EV/EBITDA
36.85
Overvalued EV/EBITDA
47.40
Undervalued EV/EBITDA
36.92

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.14
Current PS
0.07
Overvalued PS
0.22
Undervalued PS
0.05

Financials

AI Analysis
Annual
Quarterly

Whales Holding VATE

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Innovate Corp (VATE) stock price today?

The current price of VATE is 5.39 USD — it has increased 17.43

What is Innovate Corp (VATE)'s business?

Innovate Corp. is a diversified holding company. The Company has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure (DBMG), Life Sciences (Pansend), and Spectrum. The DBMG segment consists of DBM Global Inc., which is a fully integrated construction company offering both construction and professional services primarily through its core subsidiaries. It provides services, including design-assist, modularization, fabrication and erection of structural steel, heavy steel plate, trusses and girders, heavy equipment installation, as well as facility services for maintenance and shutdowns. Life Sciences segment consists of Pansend Life Sciences, LLC, which is focused on supporting healthcare and biotechnology product development. Spectrum segment consists of HC2 Broadcasting Holdings Inc. and its subsidiaries. It owns and operates broadcast television stations throughout the United States.

What is the price predicton of VATE Stock?

Wall Street analysts forecast VATE stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for VATE is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Innovate Corp (VATE)'s revenue for the last quarter?

Innovate Corp revenue for the last quarter amounts to 382.70M USD, increased 61.75

What is Innovate Corp (VATE)'s earnings per share (EPS) for the last quarter?

Innovate Corp. EPS for the last quarter amounts to -0.58 USD, decreased -55.38

How many employees does Innovate Corp (VATE). have?

Innovate Corp (VATE) has 3135 emplpoyees as of March 30 2026.

What is Innovate Corp (VATE) market cap?

Today VATE has the market capitalization of 62.63M USD.